Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents

American Heart Journal

Volumn 162, Issue 6, 2011, Pages

  Gomez Lara, Josep ^a,b   Heo, Jung Ho ^a,b   Brugaletta, Salvatore ^a,b   Garg, Scot ^a,b   Garcia Garcia, Hector M ^a,b   Van Geuns, Robert Jan ^a   Silber, Sigmund ^c   Windecker, Stefan ^d   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; RESOLUTE; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY LESION; ARTICLE; CORONARY ARTERY; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; DRUG TARGETING; FEMALE; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 82555176523     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.09.010     Document Type: Article

References (26)

1. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 e1 e121 (Pubitemid 43005195)
2. L. Harrell, H. Schunkert, and I.F. Palacios Risk predictors in patients scheduled for percutaneous coronary revascularization Catheter Cardiovasc Interv 48 1999 253 260 (Pubitemid 29530053)
3. P. Madan, M.A. Elayda, and V.V. Lee Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score Am Heart J 155 2008 1068 1074
4. M. Gyongyosi, P. Yang, and A. Khorsand Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators J Am Coll Cardiol 35 2000 1580 1589 (Pubitemid 30307504)
5. J.J. Wentzel, R. Krams, and J.C. Schuurbiers Relationship between neointimal thickness and shear stress after wall stent implantation in human coronary arteries Circulation 103 2001 1740 1745 (Pubitemid 32291410)
6. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
7. M.I. Papafaklis, C.V. Bourantas, and P.E. Theodorakis The effect of shear stress on neointimal response following sirolimus- and Paclitaxel-eluting stent implantation compared with bare-metal stents in humans JACC Cardiovasc Interv 3 2010 1181 1189
8. S. Garg, and P.W. Serruys Coronary stents: looking forward J Am Coll Cardiol 56 10 Suppl 2010 S43 S78
9. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
10. D.E. Kandzari, M.B. Leon, and J.J. Popma Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial J Am Coll Cardiol 48 2006 2440 2447 (Pubitemid 44881222)
11. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
12. S. Silber, S. Windecker, and P. Vranckx Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Lancet 377 2011 1241 1247
13. J. Gomez-Lara, H.M. Garcia-Garcia, and Y. Onuma A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents JACC Cardiovasc Interv 3 2010 1190 1198
14. J. Gomez-Lara, S. Brugaletta, and V. Farooq Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up JACC Cardiovasc Interv 4 2011 789 799
15. G.G. Babu, J.M. Walker, and D.M. Yellon Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection Eur Heart J 32 2011 23 31
16. W.J. van Gaal, F.A. Ponnuthurai, and J. Selvanayagam The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention Int J Cardiol 135 2009 60 65
17. W. Schmidt, P. Lanzer, and P. Behrens A comparison of the mechanical performance characteristics of seven drug-eluting stent systems Catheter Cardiovasc Interv 73 2009 350 360
18. M.B. Leon, L. Mauri, and J.J. Popma A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554
19. J.J. Wentzel, D.M. Whelan, and W.J. van der Giessen Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution J Biomech 33 2000 1287 1295 (Pubitemid 30427325)
20. Y. Fukuda, K. Shirai, and S. Miura The impact of angulated lesions on angiographic late loss in patients with drug-eluting stent implantation J Cardiol 53 2009 396 401
21. S. Rathore, M. Terashima, and O. Katoh Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients EuroIntervention 5 2009 349 354
22. K.W. Park, C.H. Kim, and H.Y. Lee Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents Am Heart J 159 2010 446 453.e3
23. T. Chakravarty, A.J. White, and M. Buch Meta-analysis of incidence, clinical characteristics and implications of stent fracture Am J Cardiol 106 2010 1075 1080
24. J.A. Ormiston, S.R. Dixon, and M.W. Webster Stent longitudinal flexibility: a comparison of 13 stent designs before and after balloon expansion Catheter Cardiovasc Interv 50 2000 120 124 (Pubitemid 30249790)
25. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
26. Vranckx P, Cutlip DE, Mehran R, et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 2010;5:871-4.